FDA NDC Directory · JSON-LD · Markdown

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

NDC 70752-144 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerQUAGEN PHARMACEUTICALS LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214288
Dosage form / routeCAPSULE · ORAL
Active ingredientsACETAMINOPHEN (300 mg/1)
BUTALBITAL (50 mg/1)
CAFFEINE (40 mg/1)
Marketing started20240501
Package count2

External sources

Source: openFDA. Public-domain (CC0).